Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Tioconazole
Pfizer Ltd
D01AC07
Tioconazole
283mg/1ml
Medicated nail lacquer
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13100200; GTIN: 5013457017601
1 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT TROSYL® 283 MG/ML NAIL SOLUTION TIOCONAZOLE 283 MG/ML READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Trosyl is and what it is used for 2. What you need to know before you use Trosyl 3. How to use Trosyl 4. Possible side effects 5. How to store Trosyl 6. Contents of the pack and other information 1. WHAT TROSYL IS AND WHAT IT IS USED FOR This medicine contains tioconazole, which is one of a group of medicines called antifungals. Trosyl is used in adults and children to treat nail infections caused by certain fungi. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE TROSYL DO NOT USE TROSYL: • If you have ever had an allergic reaction to tioconazole or any of the other ingredients of this medicine (listed in section 6). • If you have ever had an allergic reaction to any other medicines you have taken or used to treat fungal infection. • If you are pregnant. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using Trosyl: • If you are breast-feeding as you may be told to stop during your treatment. Make sure you do not put this medicine in your eyes. PREGNANCY AND BREAST-FEEDING If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. 2 3. HOW TO USE TROSYL Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. • Apply the nail solution thinly t Read the complete document
OBJECT 1 TROSYL NAIL SOLUTION Summary of Product Characteristics Updated 25-Jul-2013 | Pfizer Limited 1. Name of the medicinal product Trosyl 283 mg/ml Nail Solution 2. Qualitative and quantitative composition Tioconazole 283 mg/ml. For the full list of excipients, see section 6.1. 3. Pharmaceutical form Cutaneous solution. A clear pale yellow solution for topical application. 4. Clinical particulars 4.1 Therapeutic indications Tioconazole is a broad spectrum imidazole antifungal agent. Trosyl Nail Solution is indicated for the topical treatment of nail infections due to susceptible fungi (dermatophytes and yeasts) and bacteria. 4.2 Posology and method of administration _Route of administration: _Topical. _ADULTS_ The solution should be applied to the affected nails and immediately surrounding skin every twelve hours using the applicator brush supplied. The duration of treatment is up to six months but may be extended to twelve months. _USE IN THE ELDERLY_ No special precautions are required. Use the adult dose. _USE IN CHILDREN_ No special precautions are required. Use the adult dose. 4.3 Contraindications Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Trosyl Nail Solution is contraindicated in individuals who have been shown to be hypersensitive to imidazole antifungal agents. Use is contraindicated during pregnancy (see section 4.6). 4.4 Special warnings and precautions for use Trosyl Nail Solution is not for ophthalmic use. 4.5 Interaction with other medicinal products and other forms of interaction None known. 4.6 Fertility, pregnancy and lactation Pregnancy In animal studies tioconazole was not teratogenic. At high doses it increased the incidence of renal abnormalities in rat embryos, but this effect was minor and transient and was not evident in weaned animals. There is insufficient evidence as to the drug's safety in human pregnancy although absorption after topical administration is negligible. Because of the extensive duration of treatment required for nail Read the complete document